Aridhia Appointed to UK Government’s G-Cloud Framework
News Jun 03, 2014
Health and biomedical informatics company, Aridhia, has been accepted onto the UK government’s G-Cloud Framework. This means that AnalytiXagility, the advanced analytics platform for collaborative data science developed by Aridhia, is now available for the first time through CloudStore’s pay-as-you-go model.
The AnalytiXagility platform delivers on demand collaborative, secure, analytical workspaces allowing multi-disciplinary teams to connect with, load and analyse data sets of all sizes. AnalytiXagility also offers specific sector capability such as the DiabetesDataProfiler within the Healthcare sector, in addition to its core collaborative, analytic and security capability.
Data-driven healthcare will enable integrated chronic disease management ultimately improving patient outcomes through effective, efficient service delivery and, in time, transforming healthcare delivery.
Healthcare is an area particularly suited for AnalytiXagility as Chris Roche, CCO of Aridhia, explains: “Healthcare has been slow to embrace the cloud, in large part due to a lack of confidence in the security of data and the rigour of information governance.
“The beauty of AnalytiXagility is that information governance has been built in from the start to the clinically led design. Full audit traceability, information sharing agreements and connection to the N3 environment via our Skyscape partners were key design principles.”
AnalytiXagility offers choice. Experienced data science teams can subscribe to workspaces, load their data and, using the inbuilt tools, discover and visualise data in seconds. They also have access to the AnalytiXagility Lab microsite, the platform’s comprehensive educational content.
Other users can work in partnership with the SHIP approved data science team at Aridhia via the Data Lab Services available.
And, for those who just want answers, starting with Diabetes, Government Health organisations can connect their data sets to AnalytiXagility’s recent developed Diabetes DataProfiler and the inbuilt models transform the source data into actionable insight rapidly, regularly and at a price per patient. Aridhia has plans to develop other sector specific applications in the coming months.
Roche comments: “It was important for Aridhia to offer choice. Not everyone wants to manipulate data, so the totally managed service approach works for them, such as the Diabetes DataProfiler, others would like to increase their maturity in data science and informatics so access to our approved team of data scientists is an option.
“The more experienced user just avails of the workspace and has all the advanced tools they need to rapidly produce results.”
G-Cloud differs from other frameworks in that organisations pay for services as they use them, rather than being tied to inflexible, long-term contracts.
Simon Hansford, CTO of Skyscape Cloud Services, says: "We look forward to continuing our work with Aridhia in providing transformational IT services to the UK public sector and supporting the Government's Digital Strategy. Not only has G-Cloud made excellent progress to date in creating a more open marketplace – increasing opportunities for innovative, smaller suppliers to win high-profile contracts – but it has enabled public sector organisations to benefit from high-value, cost-effective IT solutions, which ultimately benefit each and every UK citizen and tax payer."
AnalytiXagility was in part inspired by the DECIPHER Health project, a 2 year industry-led collaboration with Aridhia, NHS Tayside, the University of Dundee, NHS Lothian, the University of Edinburgh and the Cancer Research UK funded cancer and part funded by the Technology Strategy Board through their Stratified Medicine Innovation competition. It is currently deployed at the Stratified Medicine Scotland Innovation Centre which brings together experts from academia, industry and the NHS in Scotland to implement a biomedical informatics service to aid clinical and translational research and enable stratified medicine.
Computer scientists at Carnegie Mellon University say neural networks and supervised machine learning techniques can efficiently characterize cells that have been studied using single cell RNA-sequencing (scRNA-seq). This finding could help researchers identify new cell subtypes and differentiate between healthy and diseased cells.